Premier News
Our recent announcements and latest news
Clinical Research: Phase 1 - Phase 4
Alternative Designs to the Traditional 3+3 Design in Phase 1 Dose Escalation Studies, Upcoming Webinar
TORONTO (PRWEB) FEBRUARY 08, 2021 Phase 1 clinical trials aim to determine the maximum tolerated dose (MTD) of a new molecule with the goal of identifying a recommended Phase 2 dose (RP2D), often the MTD itself. Ideally, the RP2D would have adequate therapeutic effect to demonstrate preliminary signs of efficacy in Phase 2, but many...
Data Management & Biostatistics
Premier Research Vice President, Statistical Consulting, Recognized by AMSTAT for Black History Month
DURHAM, N.C., February 1, 2021 — Premier Research, the clinical research company that delivers outcome-focused insights which support sponsors in developing life-changing therapies, announced today that Abie Ekangaki, Ph.D., Vice President, Statistical Consulting, has been recognized by the American Statistical Association (AMSTAT) in celebration of Black History Month. Dr. Ekangaki is one of ten Black...
Clinical Research: Phase 1 - Phase 4
Drug and Device Development Secrets in the World of Medical Aesthetics, Upcoming Webinar
TORONTO (PRWEB) NOVEMBER 09, 2020 New treatment options for aesthetic indications are in record-high demand, fueled by an aging population, and a growing focus on aesthetic issues related to nutritional habits, sedentary lifestyles, the complex stresses of 21st-century life and rising awareness about aesthetic solutions in all adult age groups. The search for more effective,...